TELA Bio, Inc. (TELA) vs Talis Biomedical Corporation (TLIS)
TELA Bio, Inc. and Talis Biomedical Corporation are both Medical Devices companies. TELA Bio, Inc. is the larger, with a market value of $57.3M against $46.3M — 1.2× the size. TELA Bio, Inc. grew revenue faster over the last twelve months: 6.09% against −65.2%. Talis Biomedical Corporation has the higher net margin (0.00% vs −51.5%) and the higher return on invested capital (0.00% vs −217.1%). Across the 17 metrics below, Talis Biomedical Corporation leads on 9 and TELA Bio, Inc. on 8.
Valuation
Profitability
| Metric | TELA | TLIS | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.29% | 97.27% | 56.01% |
| Operating margin | (42.56%) | 0.00% | (15.03%) |
| Net margin | (51.53%) | 0.00% | (20.40%) |
| Free cash flow margin | (39.57%) | 0.00% | (7.24%) |
| Return on equity | 1,232.54% | (70.48%) | (15.32%) |
| Return on assets | (64.71%) | (52.13%) | (19.72%) |
| Return on invested capital | (217.11%) | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack